OMAHA, Neb. (WOWT) — A man’s incredible response to a new congestive heart failure therapy at Nebraska Medicine is offering hope for others suffering from the condition. Steve Turner, 75, of Elk Horn, ...

SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...

Heart failure is a complex clinical syndrome of symptoms and signs that happen when the heart is not working well enough, leading to reduced blood flow to body tissues. It can lead to oedema in the ...

BUFFALO, N.Y. — It is considered groundbreaking technology in Buffalo when it comes to heart health. Cardiac Contractility Modulation Therapy (CCM) is a device that can be implanted in patients. There ...

Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Bayer AG; Bristol-Myers Squibb; Medtronic; Merck/Schering Plough; Boston Scientific Corporation; Daiichi-Sankyo/Elil Lilly and Company; Edwards ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

(WNDU) - More than 6.5 million Americans are living with heart failure. In the next five years, that number will grow to 8.5 million people. It’s the leading cause of death for men and women. It’s a ...

BOSTON, Dec. 14, 2022 /PRNewswire/ -- Valo Health, Inc ("Valo") shared the initial results of a collaborative study with the U.S. Food and Drug Administration (FDA), demonstrating the potential of ...

Cleveland Clinic is the first in the world to implant a dual cardiac device that potentially treats heart failure symptoms. The surgery was part of a clinical study to evaluate the effectiveness of a ...

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...

The evidence on cardiac contractility modulation device implantation for heart failure raises no major safety concerns. However, the evidence on efficacy is inadequate in quantity and quality.